Emphasizing the medical necessity of these drugs for patients with diabetes can help reframe the public narrative
The TriNetX platform has been used in retrospective cohort studies [25,26,27,28,29,30,31,32,33,34,35,36,37,38] including evaluating risk and health outcomes of patients with substance use disorders including CUD [25, 32, 35] and the associations of GLP-1RAs with cancer [37] and semaglutide with suicidal ideations [38]
Active or recent pancreatitis contraindicates use
Tirzepatide is a first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist
While these companies share some similarities, there are some differences in the medications they prescribe and the overall structure of their program offerings